Moneta Group Investment Advisors LLC Abbott Laboratories Transaction History

Moneta Group Investment Advisors LLC

$5.03 Billion
Q4 2023

A detailed history of Moneta Group Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 41,454 shares of ABT stock, worth $4.31 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

41,454

Previous 41,097 0.87%

Holding current value

$4.31 Million

Previous $3.98 Million 14.62%

% of portfolio

0.09%

Previous 0.09%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$90.19 - $110.4 $32,197 - $39,412	357 Added 0.87%	41,454 $4.56 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $301,970 - $362,313	-3,161 Reduced 7.14%	41,097 $3.98 Million
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $965,270 - $1.08 Million	9,578 Added 27.62%	44,258 $4.83 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $370,489 - $436,088	3,825 Added 12.4%	34,680 $3.51 Million
Q4 2022 Feb 16, 2023	BUY	$95.06 - $111.52 $57,796 - $67,804	608 Added 2.01%	30,855 $3.39 Million

Q4 2022 Feb 16, 2023	SELL	$95.06 - $111.52 $2.87 Billion - $3.37 Billion	-30,217,189 Reduced 99.9%	30,247 $3.32 Million
Q4 2022 Feb 15, 2023	BUY	$95.06 - $111.52 $2.87 Billion - $3.37 Billion	30,218,560 Added 104649.4%	30,247,436 $3.32 Billion
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $199,132 - $230,557	-2,058 Reduced 6.65%	28,876 $2.79 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $609,153 - $736,272	5,968 Added 23.9%	30,934 $3.36 Million
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $29,759 - $36,289	261 Added 1.06%	24,966 $2.96 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $38,587 - $47,247	334 Added 1.37%	24,705 $3.48 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $231,103 - $255,667	-1,981 Reduced 7.52%	24,371 $2.88 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $37,978 - $44,706	359 Added 1.38%	26,352 $3.06 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $777,335 - $915,818	7,142 Added 37.89%	25,993 $3.12 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $736,680 - $802,770	7,016 Added 59.28%	18,851 $2.06 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $129,395 - $157,141	1,412 Added 13.55%	11,835 $1.29 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $96,554 - $123,578	1,261 Added 13.76%	10,423 $953,000
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $9,988 - $14,605	159 Added 1.77%	9,162 $723,000
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $75,762 - $84,341	-965 Reduced 9.68%	9,003 $782,000
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $152,140 - $164,967	1,859 Added 22.93%	9,968 $834,000
Q2 2019 Aug 16, 2019	SELL	$72.88 - $85.0 $4.76 Million - $5.55 Million	-65,298 Reduced 88.95%	8,109 $682,000
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $4.68 Million - $5.46 Million	64,250 Added 701.65%	73,407 $682,000
Q1 2019 May 16, 2019	SELL	$66.22 - $80.06 $3.35 Million - $4.05 Million	-50,538 Reduced 84.66%	9,157 $732,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $3.28 Million - $3.96 Million	49,464 Added 483.47%	59,695 $732,000
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $458,329 - $519,221	6,991 Added 215.77%	10,231 $740,000
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $272,672 - $328,946	-4,484 Reduced 58.05%	3,240 $238,000
Q2 2018 Aug 15, 2018	SELL	$57.57 - $63.54 $118,479 - $130,765	-2,058 Reduced 21.04%	7,724 $471,000
Q2 2018 Aug 15, 2018	SELL	$57.57 - $63.54 $2.63 Million - $2.9 Million	-45,646 Reduced 82.35%	9,782 $471,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $3.02 Million - $3.34 Million	52,494 Added 1789.16%	55,428 $544,000
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $6,527 - $7,379	116 Added 4.12%	2,934 $176,000
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $151,270 - $161,950	2,818	2,818 $161,000

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Account

Moneta Group Investment Advisors LLC Abbott Laboratories Transaction History